Literature DB >> 32256036

Huntington's disease with comorbid myasthenia gravis: a case report.

S Chatzikonstantinou1, I Dagklis1, D Kazis1, E Karantali1, S Bostantjopoulou1.   

Abstract

BACKGROUND: In the literature, several reports are describing the coexistence of Huntington's disease (HD) or myasthenia gravis (MG) with other neurodegenerative and autoimmune disorders. Herein, we report a rare case of HD in a 66-year-old male with MG. Description of the case:  The diagnosis of MG was established by acetylcholine receptor antibodies testing and compatible clinical presentation. The diagnosis of HD was based on clinical features, family history, and DNA testing. Several immunologic mechanisms have been proposed regarding the pathogenesis of HD and MG, respectively. Sharing a common autoimmune aspect could be an uncertain but potential association between the two disorders.
CONCLUSION: The probability of HD and MG occurring in the same patient is extremely small. While a number of neurological and autoimmune disorders have been reported with HD and MG, this is the first described coexistence of these two entities. HIPPOKRATIA 2019, 23(1): 28-29. Copyright 2019, Hippokratio General Hospital of Thessaloniki.

Entities:  

Keywords:  Huntington’s disease; coexistence; management complexities; myasthenia gravis

Year:  2019        PMID: 32256036      PMCID: PMC7124878     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  16 in total

Review 1.  Serum levels of matrix metalloproteinases: implications in clinical neurology.

Authors:  Fredrik Romi; Geir Helgeland; Nils Erik Gilhus
Journal:  Eur Neurol       Date:  2012-01-19       Impact factor: 1.710

2.  Coexistence of Huntington's disease and amyotrophic lateral sclerosis: a clinicopathologic study.

Authors:  Mari Tada; Elizabeth A Coon; Alexander P Osmand; Patricia A Kirby; Wayne Martin; Marguerite Wieler; Atsushi Shiga; Hiroe Shirasaki; Masayoshi Tada; Takao Makifuchi; Mitsunori Yamada; Akiyoshi Kakita; Masatoyo Nishizawa; Hitoshi Takahashi; Henry L Paulson
Journal:  Acta Neuropathol       Date:  2012-06-27       Impact factor: 17.088

Review 3.  Seminar on choreas.

Authors:  Francisco Cardoso; Klaus Seppi; Katherina J Mair; Gregor K Wenning; Werner Poewe
Journal:  Lancet Neurol       Date:  2006-07       Impact factor: 44.182

4.  Amyotrophic lateral sclerosis and Huntington's disease: neurodegenerative link or coincidence?

Authors:  Suresh Kumar Chhetri; Rejith Dayanandan; Dorothea Bindman; David Craufurd; Tahir Majeed
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-07-16       Impact factor: 4.092

Review 5.  Myasthenia Gravis.

Authors:  Nils E Gilhus
Journal:  N Engl J Med       Date:  2016-12-29       Impact factor: 91.245

6.  Is it just a coincidence? Three new cases of Myasthenia Gravis associated with Parkinson's disease.

Authors:  G Sciacca; A Nicoletti; G Mostile; V Dibilio; L Raciti; A Luca; E Reggio; M Zappia
Journal:  Parkinsonism Relat Disord       Date:  2016-04-12       Impact factor: 4.891

7.  Presentation of multiple sclerosis with comorbid Huntington's disease.

Authors:  Heidi W Maloni; Mitchell T Wallin
Journal:  Clin Neurol Neurosurg       Date:  2015-05-29       Impact factor: 1.876

8.  Amyotrophic lateral sclerosis and myasthenia gravis: association or chance occurrence?

Authors:  Silvia de Pasqua; Francesco Cavallieri; Roberto D'Angelo; Fabrizio Salvi; Nicola Fini; Roberto D'Alessandro; Rita Rinaldi; Antonio Fasano; Jessica Mandrioli
Journal:  Neurol Sci       Date:  2016-12-02       Impact factor: 3.307

9.  Co-segregation of Huntington disease and hereditary spastic paraplegia in 4 generations.

Authors:  Marios Panas; Georgia Karadima; Nikolaos Kalfakis; Dimitris Vassilopoulos
Journal:  Neurologist       Date:  2011-07       Impact factor: 1.398

Review 10.  Neuroimmunology of Huntington's Disease: Revisiting Evidence from Human Studies.

Authors:  Natalia P Rocha; Fabiola M Ribeiro; Erin Furr-Stimming; Antonio L Teixeira
Journal:  Mediators Inflamm       Date:  2016-08-08       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.